中原仁

ナカハラジン | Nakahara Jin

所属機関・部署：
職名：教授
その他の所属（所属・部署名・職名） (3件)：

ホームページURL (1件)： https://www.neurology.med.keio.ac.jp/

研究分野 (1件)：神経内科学

研究キーワード (7件)：髄鞘再生療法 , 髄鞘 , 視神経脊髄炎関連疾患 , 神経内科学 , 神経免疫学 , 多発性硬化症 , オリゴデンドロサイト

競争的資金等の研究課題 (10件)：

全件表示

論文 (116件)：

Takizawa T, Ihara K, Watanabe N, Takemura R, Takahashi N, Miyazaki N, Shibata M, Suzuki K, Imai N, Suzuki N, et al. CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society. Journal of Headache and Pain. 2024. 25. 1
Nakashima I, Nakahara J, Yasunaga H, Yamashita M, Nishijima N, Satomura A, Nio M, Fujihara K. Real-world management of patients with neuromyelitis optica spectrum disorder using satralizumab: Results from a Japanese claims database. Multiple Sclerosis and Related Disorders. 2024. 84
Kurihara K, Fujioka S, Mizutani Y, Watanabe H, Iwaoka K, Maeda T, Seki M, Tezuka T, Nakahara J, Konno T, et al. Validation study of the Japanese version of the King's Parkinson's Disease Pain Scale and the King's Parkinson's Disease Pain Questionnaire. Parkinsonism and Related Disorders. 2024. 120
Motegi H, Kufukihara K, Kitagawa S, Sekiguchi K, Hata J, Fujiwara H, Jinzaki M, Okano H, Nakamura M, Iguchi Y, et al. Non-lesional white matter changes depicted by q-space diffusional MRI correlate with clinical disabilities in multiple sclerosis. Journal of the Neurological Sciences. 2024. 456. 122851-122851
Okusa S, Takizawa T, Imai S, Oyama M, Ishizuchi K, Nakahara J, Hori S, Suzuki S. Serious Bacterial Infections Associated with Eculizumab: A Pharmacovigilance Study. Internal Medicine. 2024. 63. 8. 1061-1066

MISC (5件)：

Ihara K, Takizawa T, Watanabe N, Nakahara J, Martelletti P. Potential benefits and possible risks of CGRP-targeted multitherapy in migraine. Expert Opinion on Drug Metabolism and Toxicology. 2024. 20. 1-2. 1-4
Ihara K, Ohtani S, Watanabe N, Takahashi N, Hori S, Nakahara J, Takizawa T. Response to letter: “Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule” by Suzuki et al. Journal of the Neurological Sciences. 2023. 455
Ishizuchi K, Takizawa T, Sekiguchi K, Motegi H, Oyama M, Nakahara J, Suzuki S. Flare of myasthenia gravis induced by COVID-19 vaccines. Journal of the Neurological Sciences. 2022. 436. 120225-120225
Nakahara J. Time to revisit B cells in multiple sclerosis. Clinical and Experimental Neuroimmunology. 2021. 12. 4
Ishizuchi K, Takizawa T, Tezuka T, Takahata K, Seki M, Tabuchi H, Ueda R, Kubota M, Mimura M, Nakahara J, et al. A case of progressive supranuclear palsy with predominant cerebellar ataxia diagnosed by [¹⁸F]PM-PBB3 tau PET. Journal of the Neurological Sciences. 2021. 425. 117440-117440

特許 (3件)：

Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesions
Medicinal compositions containing Fc receptor γ chain activator
Fc受容体γ鎖活性化物質を含有する医薬組成物

書籍 (1件)：

Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis
Advances in Experimental Medicine and Biology 2019

学歴 (2件)：

学位 (1件)：

経歴 (6件)：

全件表示

受賞 (13件)：

全件表示

所属学会 (6件)：

日本頭痛学会 , 日本脳卒中学会 , 日本神経治療学会 , 日本神経免疫学会 , 日本神経学会 , 日本内科学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

中原 仁